FDA.reportPublic FDA data

Jylamvo 2 MG in 1 mL Oral Solution

RxCUI
2671462
RxNorm name
Jylamvo 2 MG in 1 mL Oral Solution
Display name
Jylamvo 2 MG in 1 mL Oral Solution
Full name
Jylamvo 2 MG in 1 mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JYLAMVOMETHOTREXATESHORLA ONCOLOGY INC.96e931f5-51ae-4bdf-a441-bb0dd26d4c0e2026-06-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2671462

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
96e931f5-51ae-4bdf-a441-bb0dd26d4c0eJylamvo 2 MG in 1 mL Oral Solution [PSN] · methotrexate 2 MG/ML Oral Solution [Jylamvo] [SBD] · Jylamvo 2 MG per 1 ML Oral Solution [SY]310These highlights do not include all the information needed to use JYLAMVO ® safely and effectively. See full prescribing information for JYLAMVO ® . JYLAMVO ® (methotrexate) oral solution Initial U.S. Approval: 195320251215